Product Information
GABAPENTIN 400 MG CAPSULE is a generic product labeled by Granules Pharmaceuticals Inc., priced at $0.0416 per EA under NDC 70010011801. Its NADAC has been published 253 times since Mar 10, 2021.
FDA first approved this application on Apr 6, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
400 mg/1
Manufacturer
Granules Pharmaceuticals Inc.NDC
70010011801
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
12/17/2025
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA075360FDA Approved
4/6/2005
TE Code
AB
On Market Since
9/7/2020
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN 400 MG CAPSULE has been published 253 times since Mar 10, 2021, and over the history we have for it it has declined 34.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0416 per EA |
|---|---|
| All-time high | $0.0743 (Jun 16, 2021) |
| All-time low | $0.0399 (Nov 20, 2024) |
| 52-week high | $0.0434 |
| 52-week low | $0.0416 |
| Median price | $0.0556 |
| Average price | $0.0551 |
| Largest weekly change | +23.4% (Aug 21, 2024) |
| Weeks tracked | 253 |
| Tracking since | Mar 10, 2021 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-4.1%
3Y
-31.4%
5Y
-42.7%
All
-34.5%
Last surveyed Jan 7, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Granules Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
GABAPENTIN market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GABAPENTIN 400 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 400 MG CAPSULE, manufactured by Granules Pharmaceuticals Inc., is $0.0416 per EA (NDC 70010011801), effective Jan 7, 2026.
How has the price of GABAPENTIN 400 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for GABAPENTIN 400 MG CAPSULE has declined 34.5%. It has been tracked across 253 weekly CMS publications since Mar 10, 2021.
What are the highest and lowest recorded NADAC prices for GABAPENTIN 400 MG CAPSULE?
Since Mar 10, 2021, the NADAC for GABAPENTIN 400 MG CAPSULE has ranged from a low of $0.0399 (Nov 20, 2024) to a high of $0.0743 (Jun 16, 2021), with a median of $0.0556 per EA.
Are there cheaper alternatives to GABAPENTIN 400 MG CAPSULE?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GABAPENTIN 400 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures GABAPENTIN 400 MG CAPSULE?
GABAPENTIN 400 MG CAPSULE (NDC 70010011801) is labeled by Granules Pharmaceuticals Inc., and CMS classifies it as a generic product.